| Imatinib Mesylate studied in …STUDIED_INderived188 of 188show fewer |
|---|
| → studied in | NCT03516279Phase 2 · active not recruiting Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease · 188 trials list this drug (6 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00070499Phase 2 · active not recruiting Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia · 188 trials list this drug (6 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03007147Phase 3 · active not recruiting Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia · 188 trials list this drug (6 active) | — | — | Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia,T Acute Lymphoblastic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01742299Phase 4 · completed Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator · 188 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06655246Phase 1 · recruiting A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor,Malignant Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00015847Phase 2 · terminated Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05385549Phase 2 · recruiting 5 Years of Adjuvant Imatinib in Patients With Gastrointestinal Stromal Tumor With a High Risk · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01751425Phase 1 · terminated Ruxolitinib in Treating Participants With Chronic Myeloid Leukemia With Minimal Residual Disease While on Therapy With Tyrosine Kinase Inhibitors · 188 trials list this drug (6 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01085617completed Standard Chemotherapy with or Without Nelarabine or Rituximab in Treating Patients with Newly Diagnosed Acute Lymphoblastic Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00483366Phase 1 · completed Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors · 188 trials list this drug (6 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01738139Phase 1 · completed Ipilimumab and Imatinib Mesylate in Advanced Cancer · 188 trials list this drug (6 active) | — | — | Solid Neoplasm,Malignant Solid Neoplasm,Melanoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04006769early Phase 1 · completed Entacapone Combination With Imatinib for Treatment of GIST · 188 trials list this drug (6 active) | — | — | Malignant Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00928525Phase 2 · completed Imatinib in Patients With Desmoid Tumor and Chondrosarcoma · 188 trials list this drug (6 active) | — | — | Chondrosarcoma,Desmoid Fibromatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00161213Phase 2 · completed Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer · 188 trials list this drug (6 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05970900Phase 3 · not yet recruiting Preoperative Imatinib Mesylate Combined With Rectal-sparing Surgery in Patients With c-KIT Gene-mutant Rectal GIST · 188 trials list this drug (6 active) | — | — | Rectal Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00764595Phase 2 · completed Imatinib Mesylate in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor · 188 trials list this drug (6 active) | — | — | Malignant Neoplasm,Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002514Phase 3 · completed Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00323063Phase 2 · terminated Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer · 188 trials list this drug (6 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01005914Phase 2 · terminated Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02712112Phase 2 · completed A Study of Intermittent Dosing Schedule of Imatinib in Patients With Tyrosine Kinase Inhibitor Refractory GISTs · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03023046Phase 2 · completed Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma · 188 trials list this drug (6 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00061945Phase 1/Phase 2 · completed Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia · 188 trials list this drug (6 active) | — | — | Adult Acute Lymphoblastic Leukemia,Childhood Acute Lymphoblastic Leukemia,Childhood B Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00769327Phase 2 · completed Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00171158Phase 2 · completed An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Participants With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Blast Crisis · 188 trials list this drug (6 active) | — | — | Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03688568Phase 2 · withdrawn Study of Imatinib in Children With Neurofibromatosis and Airway Tumors · 188 trials list this drug (6 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02303899Phase 2 · completed Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma · 188 trials list this drug (6 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01827930Phase 3 · terminated Phase III Trial Evaluating the Effectiveness of a Dose Adjustment of Imatinib Mesylate on the Molecular Response · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00506779Phase 1/Phase 2 · terminated Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma · 188 trials list this drug (6 active) | — | — | Malignant Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00301093Phase 1 · completed Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00028002Phase 2 · completed Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointestinal Stromal Tumor · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00510354Phase 4 · completed Treatment of Patients With Everolimus and Imatinib Mesylate Who Have Progressive Gastro Intestinal Stromal Tumors (GIST) and Are Resistant to Imatinib Mesylate · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02257541Phase 1/Phase 2 · completed BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST) · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00509093Phase 2 · completed Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00036738Phase 2 · completed Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib · 188 trials list this drug (6 active) | — | — | Adult Acute Lymphoblastic Leukemia,Childhood Acute Lymphoblastic Leukemia,Chronic Myeloid Leukemia, BCR-ABL1 Positive+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00338728Phase 2 · completed Letrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast Cancer · 188 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01578213Phase 4 · completed Validation of Digital-PCR Analysis Through Programmed Imatinib Interruption in PCR Negative CML Patients · 188 trials list this drug (6 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049127Phase 1/Phase 2 · completed Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor · 188 trials list this drug (6 active) | — | — | Adult Mixed Glioma,Adult Anaplastic Oligodendroglioma,Adult Brain Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00075400Phase 2 · completed Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer · 188 trials list this drug (6 active) | — | — | Uterine Corpus Sarcoma,Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02177825Phase 2 · terminated Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas · 188 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045669Phase 2 · completed Imatinib Mesylate in Treating Patients With Salivary Gland Cancer · 188 trials list this drug (6 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00458848Phase 2 · completed Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02538926Phase 2 · withdrawn Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma · 188 trials list this drug (6 active) | — | — | T Lymphoblastic Leukemia/Lymphoma,Adult Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02709083Phase 2 · terminated Dasatinib or Nilotinib Followed by Imatinib in Patients With Newly Diagnosed, Chronic Phase Chronic Myeloid Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia,Myeloid Leukemia,Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00038194Phase 1 · completed Phase I Trial of Fixed Dose STI571 (Imatinib Mesylate) With Escalating Doses of Docetaxel in Patients With Metastatic Androgen-Independent Prostate Cancer · 188 trials list this drug (6 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068380Phase 2 · completed A Phase II Trial of STI571 in the Treatment of Metastatic Gastric Cancer · 188 trials list this drug (6 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00103168Phase 3 · completed Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00401024Phase 1 · completed Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma · 188 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00010049Phase 1/Phase 2 · completed Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma · 188 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00074308Phase 1/Phase 2 · completed Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers · 188 trials list this drug (6 active) | — | — | Adult Solid Neoplasm,Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00090987Phase 2 · completed Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma · 188 trials list this drug (6 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00055874Phase 3 · completed Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00080665Phase 1 · completed Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer · 188 trials list this drug (6 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02812693Phase 1/Phase 2 · withdrawn Pembrolizumab and Imatinib in Patients With Locally Advanced/Metastatic Melanoma With c-KIT Mutation/Amplification · 188 trials list this drug (6 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00867113Phase 2 · completed Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST) · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00455559Phase 2 · completed Ph II Study of Perifosine Plus Gleevec for Patients With GIST · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00882206Phase 2 · terminated Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01312818Phase 2 · terminated Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) · 188 trials list this drug (6 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00331409Phase 2 · completed Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer · 188 trials list this drug (6 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00324987Phase 3 · terminated Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00702403Phase 1/Phase 2 · completed Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML · 188 trials list this drug (6 active) | — | — | Adult Acute Lymphoblastic Leukemia,Childhood Acute Lymphoblastic Leukemia,Childhood Chronic Myeloid Leukemia, BCR-ABL1 Positive+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01383447Phase 1/Phase 2 · terminated Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia · 188 trials list this drug (6 active) | — | — | Adult Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03241199Phase 2 · unknown The Efficacy and Safety of Induction-Maintenance Protocol for Patients With Chronic Myelogenous Leukaemia · 188 trials list this drug (6 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01172548Phase 2 · completed Safety and Efficacy Evaluation of Two Year Imatinib Treatment in Adjuvant Gastrointestinal Stromal Tumor (GIST) · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045734Phase 2 · completed Imatinib Mesylate in Treating Patients With Recurrent Meningioma · 188 trials list this drug (6 active) | — | — | Adult Meningioma,Meningeal Solitary Fibrous Tumor,Adult Brain Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00408460Phase 2 · completed Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer · 188 trials list this drug (6 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00171938Phase 2 · terminated Open-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors) · 188 trials list this drug (6 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00154349Phase 2 · completed Efficacy Study of Imatinib Mesylate to Treat Philadelphia-Positive Acute Lymphocytic Leukemia · 188 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00171899Phase 4 · completed Study Comparing Standard Dose and High-dose Imatinib Mesylate in Patients With Chronic Phase Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML) · 188 trials list this drug (6 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00171912Phase 2 · completed Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes · 188 trials list this drug (6 active) | — | — | Chronic Myelomonocytic Leukemia,Dermatofibrosarcoma Protuberans,Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00684411Phase 2 · completed Gleevec in Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma · 188 trials list this drug (6 active) | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00136409Phase 2 · completed A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML) · 188 trials list this drug (6 active) | — | — | Chronic Myelomonocytic Leukemia,Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00427999Phase 2 · completed Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate Cancer · 188 trials list this drug (6 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00154388Phase 2 · completed Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases · 188 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01483014Phase 2 · completed Phase ll Study of Imatinib Mesylate for the Neoadjuvant Treatment of Patients With Gastrointestinal Stromal Tumors (GIST) · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00287846Phase 1/Phase 2 · completed Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis · 188 trials list this drug (6 active) | — | — | Desmoid Fibromatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01297777Phase 4 · completed Imatinib in KIT-negative Systemic Mastocytosis · 188 trials list this drug (6 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00861471Phase 1/Phase 2 · terminated Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer · 188 trials list this drug (6 active) | — | — | Prostate Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00327678Phase 3 · completed Treatment of Acute Lymphoblastic Leukemia (ALL) in Younger Adults · 188 trials list this drug (6 active) | — | — | Lymphoid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02687425Phase 2 · unknown Safety and Efficiency Study of Pioglitazone in Combination With Imatinib Mesylate to Treat Chronic Myelogenous Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00216112Phase 2 · completed Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer · 188 trials list this drug (6 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00022490Phase 2 · terminated Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00402766Phase 1 · completed Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma · 188 trials list this drug (6 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00387933Phase 1 · completed Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma · 188 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00038610Phase 2 · completed Study of Hyper-CVAD Plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052494Phase 1 · completed Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung Cancer · 188 trials list this drug (6 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01011075Phase 2 · completed Study of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung Cancer · 188 trials list this drug (6 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039585Phase 2 · completed Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor · 188 trials list this drug (6 active) | — | — | Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00500110Phase 2 · completed Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer · 188 trials list this drug (6 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030667Phase 2 · completed Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood · 188 trials list this drug (6 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Gastrointestinal Stromal Tumor,Osteosarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01267695Phase 2 · completed Perioperative Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00114959Phase 2 · terminated Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML) · 188 trials list this drug (6 active) | — | — | Myeloid Leukemia,Chronic Myeloid Leukemia, BCR-ABL1 Positive,Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00009906Phase 3 · terminated Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470470Phase 2 · completed Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery · 188 trials list this drug (6 active) | — | — | Melanoma,Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039377Phase 2 · completed Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 188 trials list this drug (6 active) | — | — | Adult Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00430066Phase 2 · completed Effects of Imatinib Mesylate in Polycythemia Vera · 188 trials list this drug (6 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01281865Phase 1/Phase 2 · completed Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma · 188 trials list this drug (6 active) | — | — | Adult Soft Tissue Sarcoma,Adult Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00237185Phase 2 · completed A Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00686218Phase 1 · completed Panobinostat (LBH589) and Imatinib Mesylate in Treating Patients With Previously Treated Chronic Phase Chronic Myelogenous Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00021229Phase 1/Phase 2 · terminated Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma · 188 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00685828Phase 3 · unknown Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087152Phase 2 · completed S0338, Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast Cancer · 188 trials list this drug (6 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00323362Phase 2 · terminated Gemcitabine and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer · 188 trials list this drug (6 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00022737Phase 3 · completed Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia · 188 trials list this drug (6 active) | — | — | Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039416Phase 2 · completed Imatinib Mesylate in Treating Patients With Myelofibrosis · 188 trials list this drug (6 active) | — | — | Chronic Myelomonocytic Leukemia,Essential Thrombocythemia,Polycythemia Vera+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004932Phase 1 · completed STI571 in Treating Patients With Recurrent Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006052Phase 2 · completed STI571 in Treating Patients With Accelerated Phase Chronic Myelogenous Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01005758Phase 2 · unknown Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00258271Phase 1 · completed Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00333840Phase 3 · completed Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia · 188 trials list this drug (6 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049569NA · completed Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia · 188 trials list this drug (6 active) | — | — | Childhood Acute Lymphoblastic Leukemia,Childhood T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052949Phase 2 · completed Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer · 188 trials list this drug (6 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00028847Phase 1/Phase 2 · unknown Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01031628Phase 3 · terminated Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00510653Phase 2 · completed Gleevec Study for Patients With Ovarian Cancer · 188 trials list this drug (6 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00904735Phase 2 · unknown Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive Meningioma · 188 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00041197Phase 3 · completed Imatinib Mesylate in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed By Surgery · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00015860Phase 1/Phase 2 · completed STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00031915Phase 2 · completed Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma · 188 trials list this drug (6 active) | — | — | Sarcoma,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045422Phase 2 · completed Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00081133Phase 1/Phase 2 · completed Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00091078Phase 2 · terminated Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By Surgery · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049192Phase 2 · completed Oblimersen and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia · 188 trials list this drug (6 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00425646Phase 2 · completed Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer · 188 trials list this drug (6 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093639Phase 1/Phase 2 · completed Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib Mesylate · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00253565Phase 1 · completed Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors · 188 trials list this drug (6 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00066326Phase 1 · completed Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00354068Phase 1 · completed Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma · 188 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00618501Phase 2 · completed Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01221376Phase 2 · unknown Phase II Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Chronic Myeloid Leukemia (CML) Philadelphia Chromosome-positive (Ph+) · 188 trials list this drug (6 active) | — | — | Poroid Hidradenoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01222013Phase 2 · suspended Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+) · 188 trials list this drug (6 active) | — | — | Poroid Hidradenoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00601510Phase 1 · completed Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach Cancer · 188 trials list this drug (6 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068783Phase 2 · completed S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer · 188 trials list this drug (6 active) | — | — | Cutaneous Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00084630Phase 2 · completed Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans · 188 trials list this drug (6 active) | — | — | Adult Fibrosarcoma,Adult Soft Tissue Sarcoma,Dermatofibrosarcoma Protuberans | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006475Phase 2 · completed STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast Crisis · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025246Phase 2 · completed Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00041041Phase 2 · completed Imatinib Mesylate in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer · 188 trials list this drug (6 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00268229Phase 1 · completed Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025415Phase 1 · completed Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction · 188 trials list this drug (6 active) | — | — | Adult Solid Neoplasm,Anaplastic Large Cell Lymphoma,Gastrointestinal Stromal Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00015834Phase 1/Phase 2 · completed STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia · 188 trials list this drug (6 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive,Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00036751Phase 2 · completed Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer · 188 trials list this drug (6 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00041340Phase 2 · completed Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer · 188 trials list this drug (6 active) | — | — | Malignant Colon Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045188Phase 2 · completed Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer · 188 trials list this drug (6 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00054431Phase 2 · completed Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia · 188 trials list this drug (6 active) | — | — | Childhood Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Myeloid Leukemia, BCR-ABL1 Positive,Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006053Phase 2 · completed STI571 in Treating Patients With Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00354913Phase 2 · completed Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma · 188 trials list this drug (6 active) | — | — | Glioblastoma,Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030394Phase 2 · completed Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia · 188 trials list this drug (6 active) | — | — | Childhood Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00042952Phase 2 · terminated Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer · 188 trials list this drug (6 active) | — | — | Ovarian Germ Cell Tumor,Malignant Testicular Germ Cell Tumor,Testicular Seminoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101088Phase 1 · terminated Temsirolimus and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia · 188 trials list this drug (6 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive,Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00026169Phase 1 · completed Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure · 188 trials list this drug (6 active) | — | — | Malignant Neoplasm,Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006343Phase 3 · completed STI571 Compared With Interferon Alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00084825Phase 2 · completed Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008 · 188 trials list this drug (6 active) | — | — | Malignant Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00080678Phase 2 · completed Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases · 188 trials list this drug (6 active) | — | — | Malignant Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006357Phase 1/Phase 2 · completed STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma · 188 trials list this drug (6 active) | — | — | Sarcoma,Gastrointestinal Stromal Tumor,Malignant Ovarian Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085475Phase 2 · completed Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma · 188 trials list this drug (6 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00956072Phase 3 · terminated Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00219726Phase 2 · completed Safety and Efficacy of Imatinib in Chronic Myelogenous Patients in Relapse After Stem Cell Transplantation · 188 trials list this drug (6 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00171977Phase 4 · completed Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST) · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00427583Phase 2/Phase 3 · terminated Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors · 188 trials list this drug (6 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00485485Phase 2 · completed Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer · 188 trials list this drug (6 active) | — | — | Malignant Head and Neck Neoplasm,Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00386373NA · completed Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039364Phase 2 · completed Imatinib Mesylate in Treating Patients With Gliomas · 188 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00053248Phase 1/Phase 2 · completed Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00237172Phase 2 · completed Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study) · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00499889Phase 2 · terminated Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00243191Phase 2 · completed Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans · 188 trials list this drug (6 active) | — | — | Dermatofibrosarcoma Protuberans | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112632Phase 2 · completed Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00124748Phase 3 · terminated Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity) · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00245128Phase 2 · terminated Imatinib Mesylate in Treating Patients With Myelofibrosis · 188 trials list this drug (6 active) | — | — | Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01083589Phase 2 · completed Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC) · 188 trials list this drug (6 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00116935Phase 3 · completed Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST) · 188 trials list this drug (6 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00244829Phase 1/Phase 2 · completed Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01227135Phase 2 · unknown Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00110058Phase 2 · completed Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00573404Phase 1 · terminated Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01003054Phase 2 · completed Autologous Transplantation for Chronic Myelogenous Leukemia · 188 trials list this drug (6 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00763763Phase 2 · completed Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL Positive · 188 trials list this drug (6 active) | — | — | Leukemia,Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00281996Phase 1 · terminated Imatinib Mesylate and Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Pancreatic Cancer · 188 trials list this drug (6 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112775Phase 2 · unknown BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00154375Phase 3 · completed Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma · 188 trials list this drug (6 active) | — | — | Glioblastoma,Astrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00372567Phase 3 · terminated Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00417807Phase 1/Phase 2 · completed Imatinib Mesylate in Patients With Refractory Desmoplastic Small Round Cell Tumors · 188 trials list this drug (6 active) | — | — | Desmoplastic Small Round Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00064285Phase 1 · completed Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer · 188 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00084513Phase 1 · completed Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing Cancer · 188 trials list this drug (6 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00062205Phase 2 · completed Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell Tumor · 188 trials list this drug (6 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00323791Phase 2 · terminated Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer · 188 trials list this drug (6 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00594555Phase 2 · withdrawn A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia · 188 trials list this drug (6 active) | — | — | Acute Myeloid Leukemia,Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045604Phase 1 · completed Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer · 188 trials list this drug (6 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00290485Phase 2 · unknown Gleevec Administered Preoperatively to Reduce Gastrointestinal Stromal Tumor (GIST) · 188 trials list this drug (6 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |